Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases
Authors
Keywords
-
Journal
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
Volume 92, Issue 7, Pages 558-565
Publisher
Canadian Science Publishing
Online
2014-04-09
DOI
10.1139/cjpp-2013-0488
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis
- (2013) AC Simões e Silva et al. BRITISH JOURNAL OF PHARMACOLOGY
- 2013 ACCF/AHA Guideline for the Management of Heart Failure
- (2013) Clyde W. Yancy et al. CIRCULATION
- Epidemiology of Heart Failure
- (2013) Véronique L. Roger CIRCULATION RESEARCH
- Epigenetic regulation of angiotensin-converting enzyme 2 (ACE2) by SIRT1 under conditions of cell energy stress
- (2013) Nicola E. Clarke et al. CLINICAL SCIENCE
- Apelin is a positive regulator of ACE2 in failing hearts
- (2013) Teruki Sato et al. JOURNAL OF CLINICAL INVESTIGATION
- Impact of the renin–angiotensin system on cardiac energy metabolism in heart failure
- (2013) Jun Mori et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: A positive feedback mechanism in the RAS
- (2013) Vaibhav B. Patel et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- ACE2 Activation Confers Endothelial Protection and Attenuates Neointimal Lesions in Prevention of Severe Pulmonary Arterial Hypertension in Rats
- (2013) Gang Li et al. LUNG
- ACE2 – From the renin–angiotensin system to gut microbiota and malnutrition
- (2013) Thomas Perlot et al. MICROBES AND INFECTION
- Angiotensin-converting enzyme 2 attenuates oxidative stress and VSMC proliferation via the JAK2/STAT3/SOCS3 and profilin-1/MAPK signaling pathways
- (2013) Bei Song et al. REGULATORY PEPTIDES
- The pathophysiology of heart failure
- (2012) Clinton D. Kemp et al. CARDIOVASCULAR PATHOLOGY
- TheACE2gene: its potential as a functional candidate for cardiovascular disease
- (2012) Louise M. Burrell et al. CLINICAL SCIENCE
- Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar-Kyoto rats and spontaneously hypertensive rats
- (2012) Jennifer Lo et al. EXPERIMENTAL PHYSIOLOGY
- Chronic activation of endogenous angiotensin-converting enzyme 2 protects diabetic rats from cardiovascular autonomic dysfunction
- (2012) Tatiane M. Murça et al. EXPERIMENTAL PHYSIOLOGY
- Cardioprotective Effects Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin 1-7 in Experimental Heart Failure in Angiotensin-Converting Enzyme 2–Null Mice
- (2012) Vaibhav B. Patel et al. HYPERTENSION
- Possible Involvement of Angiotensin-Converting Enzyme 2 and Mas Activation in Inhibitory Effects of Angiotensin II Type 1 Receptor Blockade on Vascular Remodeling
- (2012) Masaru Iwai et al. HYPERTENSION
- ACE2, angiotensin-(1–7), and Mas: the other side of the coin
- (2012) Michael Bader PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Adenoviral Delivery of Angiotensin-(1-7) or Angiotensin-(1-9) Inhibits Cardiomyocyte Hypertrophy via the Mas or Angiotensin Type 2 Receptor
- (2012) Monica Flores-Muñoz et al. PLoS One
- Angiotensin-Converting Enzyme 2 Over-Expression in the Central Nervous System Reduces Angiotensin-II-Mediated Cardiac Hypertrophy
- (2012) Yumei Feng et al. PLoS One
- Angiotensin-(1-7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes
- (2011) Chang Liu et al. ACTA DIABETOLOGICA
- Review: Novel roles of nuclear angiotensin receptors and signaling mechanisms
- (2011) TanYa M. Gwathmey et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47phox NADPH oxidase subunit
- (2011) Sreedhar Bodiga et al. CARDIOVASCULAR RESEARCH
- CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failure
- (2011) John J.V. McMurray EUROPEAN JOURNAL OF HEART FAILURE
- Lentivirus-mediated overexpression of angiotensin-(1-7) attenuated ischaemia-induced cardiac pathophysiology
- (2011) YanFei Qi et al. EXPERIMENTAL PHYSIOLOGY
- Chronic kidney disease: cardiac and renal angiotensin-converting enzyme (ACE) 2 expression in rats after subtotal nephrectomy and the effect of ACE inhibition
- (2011) L. M. Burrell et al. EXPERIMENTAL PHYSIOLOGY
- Role of ACE2 in diastolic and systolic heart failure
- (2011) Wang Wang et al. HEART FAILURE REVIEWS
- Aerobic Exercise Training–Induced Left Ventricular Hypertrophy Involves Regulatory MicroRNAs, Decreased Angiotensin-Converting Enzyme-Angiotensin II, and Synergistic Regulation of Angiotensin-Converting Enzyme 2-Angiotensin (1-7)
- (2011) Tiago Fernandes et al. HYPERTENSION
- In search of new therapeutic targets and strategies for heart failure: recent advances in basic science
- (2011) Ajay M Shah et al. LANCET
- Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials
- (2011) A. Maione et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- ACE2-Mediated Reduction of Oxidative Stress in the Central Nervous System Is Associated with Improvement of Autonomic Function
- (2011) Huijing Xia et al. PLoS One
- Preservation of Kidney Function with Combined Inhibition of NADPH Oxidase and Angiotensin-Converting Enzyme in Diabetic Nephropathy
- (2010) Vicki Thallas-Bonke et al. AMERICAN JOURNAL OF NEPHROLOGY
- β2-Adrenoceptors, NADPH oxidase, ROS and p38 MAPK: another ‘radical’ road to heart failure?
- (2010) Fabio Di Lisa et al. BRITISH JOURNAL OF PHARMACOLOGY
- Feeding blueberry diets inhibits angiotensin II-converting enzyme (ACE) activity in spontaneously hypertensive stroke-prone rats
- (2010) Waylon Wiseman et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction
- (2010) JiuChang Zhong et al. CIRCULATION
- Angiotensin I-Converting Enzyme Type 2 (ACE2) Gene Therapy Improves Glycemic Control in Diabetic Mice
- (2010) S. M. Bindom et al. DIABETES
- Mast cell chymase limits the cardiac efficacy of Ang I–converting enzyme inhibitor therapy in rodents
- (2010) Chih-Chang Wei et al. JOURNAL OF CLINICAL INVESTIGATION
- Epidemiology and risk profile of heart failure
- (2010) Anh L. Bui et al. Nature Reviews Cardiology
- Systolic Heart Failure
- (2010) John J.V. McMurray NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells
- (2010) C. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression
- (2010) Jiu-Chang Zhong et al. REGULATORY PEPTIDES
- Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17β-oestradiol-dependent and sex chromosome-independent
- (2010) Jun Liu et al. Biology of Sex Differences
- Brain-Selective Overexpression of Human Angiotensin-Converting Enzyme Type 2 Attenuates Neurogenic Hypertension
- (2009) Yumei Feng et al. CIRCULATION RESEARCH
- SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS
- (2009) G. Y. Oudit et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2
- (2009) Jan Wysocki et al. HYPERTENSION
- Angiotensin-(1-7)-Angiotensin-Converting Enzyme 2 Attenuates Reactive Oxygen Species Formation to Angiotensin II Within the Cell Nucleus
- (2009) TanYa M. Gwathmey et al. HYPERTENSION
- Soluble Angiotensin-Converting Enzyme 2 in Human Heart Failure: Relation With Myocardial Function and Clinical Outcomes
- (2009) Slava Epelman et al. JOURNAL OF CARDIAC FAILURE
- Effects of Angiotensin-Converting Enzyme Inhibitor Therapy on Clinical Outcome in Patients Undergoing Coronary Artery Bypass Grafting
- (2009) Antonio Miceli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis
- (2008) Fina Lovren et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Angiotensin-Converting Enzyme 2 Overexpression in the Subfornical Organ Prevents the Angiotensin II–Mediated Pressor and Drinking Responses and Is Associated With Angiotensin II Type 1 Receptor Downregulation
- (2008) Yumei Feng et al. CIRCULATION RESEARCH
- The angiotensin-(1–7) receptor agonist AVE0991 is cardioprotective in diabetic rats
- (2008) Linda Ebermann et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cardiac Overexpression of Angiotensin Converting Enzyme 2 Protects the Heart From Ischemia-Induced Pathophysiology
- (2008) Shant Der Sarkissian et al. HYPERTENSION
- Transgenic Angiotensin-Converting Enzyme 2 Overexpression in Vessels of SHRSP Rats Reduces Blood Pressure and Improves Endothelial Function
- (2008) Brit Rentzsch et al. HYPERTENSION
- Angiotensin-converting enzyme 2 in the brain: properties and future directions
- (2008) Huijing Xia et al. JOURNAL OF NEUROCHEMISTRY
- Detection of Soluble Angiotensin-Converting Enzyme 2 in Heart Failure
- (2008) Slava Epelman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-κB activation via NADPH oxidase
- (2007) Yongzhong Wei et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression
- (2007) J-C Zhong et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search